Professor, Neurology, University of California, Irvine College of Medicine
Neurology
Dr. Claudia H. Kawas, MD
|
|
Give Review
Doctor Claudia H. Kawas, MD works in the field of Neurology. He went to University of Louisville School of Medicine. University of Louisville School of Medicine is ranked 83/0 in Research/PrimaryCare. Claudia Kawas is a published doctor as well. He has 101 publications published. The latest was: Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. He accepts all Medicare patients.
Publications
- Impact of interventions to reduce Alzheimer Disease pathology on the prevalence of dementia in the oldest-old.
- Lifestyle Factors and Dementia in the Oldest-old: The 90+ Study.
- Intracellular amyloid and the neuronal origin of Alzheimer neuritic plaques.
- Perforant path synaptic loss correlates with cognitive impairment and Alzheimer's Disease in the oldest-old.
- ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology.
- Exponential Increases in the Prevalence of Disability in the Oldest Old: A Canadian National Survey.
- Plasma phospholipids identify antecedent memory impairment in older adults.
- Antihypertensive drugs decrease risk of Alzheimer Disease: Ginkgo Evaluation of Memory Study.
- Neocortical ?-amyloid area is associated with Dementia and APOE in the oldest-old.
- DRD4 genotype predicts longevity in mouse and human.
- Amyloid imaging and cognitive decline in nondemented oldest-old: The 90+ Study.
- Apolipoprotein E genotype, Dementia, and mortality in the oldest old: The 90+ Study.
- Alzheimer Disease pathology and longitudinal cognitive performance in the oldest-old with no dementia.
- A Population-Based Clinicopathological Study in the Oldest-Old: The 90+ Study.
- Incidence of Dementia in oldest-old with amnestic MCI and other cognitive impairments.
- Cognitive impairment in nondemented oldest-old: Prevalence and relationship to cardiovascular risk factors.
- Diagnosing Dementia in the oldest-old.
- Activities and mortality in the elderly: the Leisure World cohort study.
- The diagnosis of dementia due to Alzheimer's Disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines ...
- Temporoparietal hypometabolism in frontotemporal lobar Degeneration and associated imaging diagnostic errors.
- Bathing as a potential target for disability reduction in the oldest old.
- EEG in Nonagenarians: Author Reply.
- Operationalizing diagnostic criteria for Alzheimer's Disease and other age-related cognitive impairment-Part 2.
- Validation of consensus panel diagnosis in Dementia.
- AbNormal EEGs in cognitively and physically healthy oldest old: findings from the 90+ study.
- Dementia incidence continues to increase with age in the oldest old: the 90+ study.
- Elevated C-reactive protein levels are associated with prevalent Dementia in the oldest-old.
- Synaptic proteins, neuropathology and cognitive status in the oldest-old.
- High levels of serum C-reactive protein are associated with greater risk of all-cause mortality, but not Dementia, in the oldest-old: results from The 90+ Study.
- APOE epsilon2 is associated with intact cognition but increased Alzheimer pathology in the oldest old.
- The oldest old and the 90+ Study.
- Non-alcoholic beverage and caffeine consumption and mortality: the Leisure World Cohort Study.
- Sensitivity and specificity of the mini-mental state examination for identifying Dementia in the oldest-old: the 90+ study.
- Medications and diet: protective factors for AD?
- Diet and the risk for Alzheimer's Disease.
- Association of body mass index and weight change with all-cause mortality in the elderly.
- Increased longevity in older users of postmenopausal estrogen therapy: the Leisure World Cohort Study.
- Reduced risk of Alzheimer's Disease with high folate intake: the Baltimore Longitudinal Study of Aging.
- Depressive symptoms, sex, and risk for Alzheimer's Disease.
- Alpha-synuclein lesions in normal aging, Parkinson Disease, and Alzheimer Disease: evidence from the Baltimore Longitudinal Study of Aging (BLSA).
- Hippocampal neurons in pre-clinical Alzheimer's Disease.
- Estrogen replacement therapy, Alzheimer's Disease, and mild cognitive impairment.
- Neuronal localization of C1q in preclinical Alzheimer's Disease.
- Clinical practice. Early Alzheimer's Disease.
- Immune reactive cells in senile plaques and cognitive decline in Alzheimer's Disease.
- Informed consent for Alzheimer's Disease clinical trials: a survey of clinical investigators.
- Neuropathologic features associated with Alzheimer Disease diagnosis: age matters.
- Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal Brain.
- Classification of vascular Dementia in the Cardiovascular Health Study Cognition Study.
- Determinants of vascular Dementia in the Cardiovascular Health Cognition Study.
- Neuropsychological characteristics of mild cognitive impairment subgroups.
- Neuropsychological function in nondemented carriers of presenilin-1 mutations.
- Calcium channel blockers and risk of AD: the Baltimore Longitudinal Study of Aging.
- Female preclinical presenilin-1 mutation carriers unaware of their genetic status have higher levels of depression than their non-mutation carrying kin.
- Free testosterone and risk for Alzheimer Disease in older men.
- Development of dementing illnesses in an 80-year-old volunteer cohort.
- Reversible Dementia with idiopathic hypereosinophilic syndrome.
- Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's Disease.
- Age-specific norms for the Mini-Mental State Exam.
- Impaired ranking of semantic attributes in Dementia.
- Age-associated changes in specific errors on the Benton Visual Retention Test.
- Adult life span changes in immediate visual memory and verbal intelligence.
- Nonsteroidal anti-inflammatory drugs in Alzheimer's Disease.
- A validation study of the Dementia Questionnaire.
- Changes in semantic memory in early stage Alzheimer's Disease patients.
- Predicting rate of cognitive decline in probable Alzheimer's Disease.
- Risk of Alzheimer's Disease and duration of NSAID use.
- Learning and retention in preclinical and early Alzheimer's Disease.
- A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's Disease: the Baltimore Longitudinal Study of Aging.
- Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer Disease.
- The Direct Assessment of Functional Abilities (DAFA): a comparison to an indirect measure of instrumental activities of daily living.
- Diagnostic validity of the dementia questionnaire for Alzheimer Disease.
- Sources of variability in prevalence rates of Alzheimer''s Disease.
- Reliability of the Blessed Telephone Information-Memory-Concentration Test.
- Projections of Alzheimer's Disease in the United States and the public health impact of delaying Disease onset.
- Systolic blood Pressure within an intermediate range may reduce memory loss in an elderly hypertensive cohort.
- Women and alzheimer Disease.
- Estrogen replacement therapy for treatment of mild to moderate Alzheimer Disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study.
- Age-specific incidence rates of Alzheimer's Disease: the Baltimore Longitudinal Study of Aging.
- The relationship between longitudinal declines in dehydroepiandrosterone sulfate concentrations and cognitive performance in older men.
- The CA1 region of the human hippocampus is a hot spot in Alzheimer's Disease.
- Modulation of amyloid beta-protein clearance and Alzheimer's Disease susceptibility by the LDL receptor-related protein pathway.
- Frontiers in human behavioral science.
- Aging and the public health effects of Dementia.
- APOE genotype and survival in men and women with Alzheimer's Disease.
- Clinical trials in Alzheimer Disease: debate on the use of placebo controls.
- Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging.
- Neuropathology of preclinical and clinical late-onset Alzheimer's Disease.
- Lack of relation between race and cognitive test performance in Alzheimer's Disease.
- Neuronal cell death in Alzheimer's Disease correlates with apoE uptake and intracellular Abeta stabilization.
- Apolipoprotein E genotype and rate of decline in probable Alzheimer's Disease.
- Lack of association of the apoE4 allele with hippocampal sclerosis Dementia.
- In situ labeling of dying cortical neurons in normal aging and in Alzheimer's Disease: correlations with senile plaques and Disease progression.
- Establishing advance medical directives with demented patients: a pilot study.
- Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer''s Disease.
- Cognitive problems in the elderly.
- Microtransplantation of functional receptors and channels from the Alzheimer's Brain to frog oocytes.
- Visual memory predicts Alzheimer's Disease more than a decade before diagnosis.
- A molecular hybridization study for the presence of Herpes simplex, cytomegalovirus and Epstein-Barr virus in brain and blood of Alzheimer''s Disease patients.
- Survival following dementia onset: Alzheimer''s Disease and vascular dementia.
Schools
University of Louisville School of Medicine
Meml Hospital
Einstein College Med
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Brain Injury
- Convulsions
- View All
Doctors Specialties
- Neurology
Accepted Insurances
- Blue Card PPO
- Blue Cross Blue Shield of California PPO
- First Health (Coventry Health Care) PPO
- Blue & Gold HMO
- Covered California - Bronze PPO
- Health Net PPO
- Individual and Family PPO
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- PacifiCare HMO
Education
-
Albert Einstein College of Medicine at Jacobi Medical Center -
University of Louisville School of Medicine
Hospital
-
UC Irvine Medical Center
Drug Facts
| NPI NUMBER | 1629158894 | |
| NPPES Provider LastName | KAWAS | |
| NPPES Provider FirstName | CLAUDIA | |
| NPPES Provider ZIPCode | 92868 | |
| NPPES Provider State | CA | |
| Specialty Description | Neurology | |
| Total Claim Count | 26.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1629158894 |
| Last Name Of The Provider | KAWAS |
| First Name Of The Provider | CLAUDIA |
| View All |
Similar Doctors
|
|
Dr. Sarah L. Maze, MD |
|
|
Dr. Brian J. Boyd, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yama Akbari, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hermelinda G. Abcede, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jose A. Carrillo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leonid I. Groysman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John H. Weiss, MD |
|
|
Dr. Lama Al-Khoury, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aradia X. Fu, MD |
|
|
Dr. Leif A. Havton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nassim Naderi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janne K. Nissinen, MD |